Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Both type 1 and type 2 diabetes~2. HbA1c 7-11%~3. Treated with MDI for at least 3 months~4. Ability to use the system at home, mobile phone~Exclusion Criteria:~1. Active CAD, CVA during last 6 months~2. Treatment with steroids or other glucose modifying drugs~3. Chronic infection/cancer/other severe disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- GlucoMe App (Type: EXPERIMENTAL): Self monitoring of glucose blood measurements using the GlucoMe glucose monitoring glucose device and App

Based on this trial design, predict the completion outcome and termination type (if applicable).